medicationPrescription only (US)
MetforminBenefits, Dosage & Interactions
Metformin is an oral medication primarily used to manage type 2 diabetes. It belongs to a class of drugs called biguanides. It is typically taken with a meal. The reported plasma half-life is about 6.2 hours, which shapes dosing frequency.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 1 human randomized trial and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1 human randomized trial and regulatory approval on file.
Plasma half-life
~6.2 h
Typical timing
with meal
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- Labels describe 500 mg to 2550 mg/day for immediate-release metformin, titrated upward[1]
- Route studied
- Oral[1]
- Frequency
- Once to three times daily with meals, depending on formulation[1]
- Cycle length
- Continuous therapy; median 10 years of follow-up in UKPDS[1]
- Half-life
- Approximately 6.2 hours in plasma[1]
- Storage
- Room temperature[1]
Reported for Metformin in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Metformin entry is written from. Each number matches an inline marker above.
- [1]Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33/34)UK Prospective Diabetes Study (UKPDS) Group · The Lancet · 1998 · Peer-reviewed · PMID 9742976
How to track Metformin doses
Tracking Metformin well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Metformin with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is with_meal. Take it with food, and record it that way so absorption stays consistent. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Metformin through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 6.2 h, effects and timing shifts show up over days rather than instantly. Review Metformin alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day and whether it was taken with food
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Metformin dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Metformin?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Metformin is an oral medication primarily used to manage type 2 diabetes. It belongs to a class of drugs called biguanides. It works by improving how the body uses insulin, lowering glucose production in the liver, and decreasing glucose absorption from the intestines. While its main use is for blood sugar control, it is sometimes used off-label for other conditions like polycystic ovary syndrome (PCOS) and has been investigated for potential benefits in longevity and weight management due to its metabolic effects. Metformin is a prescription medication and its use should always be directed by a licensed healthcare professional. (NIH ODS)
What does the research say about Metformin?
Tap a section to expand.
Metformin primarily works through several mechanisms to lower blood glucose levels:
* **Decreases Hepatic Glucose Production:** It reduces the amount of glucose produced by the liver (gluconeogenesis). This is considered its main action. It does this by inhibiting complex I of the mitochondrial respiratory chain, which leads to activation of AMP-activated protein kinase (AMPK). Activated AMPK then reduces the expression of genes involved in glucose synthesis in the liver.
* **Improves Insulin Sensitivity:** Metformin enhances the sensitivity of muscle and fat cells to insulin, meaning these cells can take up glucose from the blood more efficiently in response to insulin.
* **Decreases Intestinal Glucose Absorption:** It can reduce the absorption of glucose from the gastrointestinal tract.
* **Modulates the Gut Microbiome:** Emerging research suggests Metformin may also exert some of its effects by altering the composition and function of gut microbiota. (DrugBank, PubChem)
Source for this section: Sources for How does Metformin work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefit of Metformin is the **control of blood glucose levels in individuals with type 2 diabetes**. This helps prevent or delay the long-term complications associated with elevated blood sugar, such as cardiovascular disease, kidney damage, nerve damage, and eye problems. (EMA SmPC)
Beyond its main indication, Metformin has been explored for other potential benefits:
* **Weight Management:** While not a primary weight-loss drug, some individuals, particularly those with insulin resistance or type 2 diabetes, may experience modest weight loss when taking Metformin. This is thought to be due to its effects on appetite, gut hormone release, and metabolic pathways. (Cochrane)
* **Polycystic Ovary Syndrome (PCOS):** Metformin is often used off-label to improve symptoms of PCOS, including insulin resistance, irregular periods, and infertility. It can help normalize menstrual cycles and improve ovulation in some women with PCOS. (MedlinePlus)
* **Cardiovascular Benefits:** Studies suggest Metformin may have protective effects on the cardiovascular system independently of its glucose-lowering effects, potentially by improving endothelial function and reducing inflammation. (Cochrane)
* **Longevity Research:** Metformin has garnered significant interest in the longevity field due to its impact on metabolic pathways, including AMPK activation. Preclinical studies suggest it may extend lifespan in some organisms, and clinical trials are investigating its potential to delay age-related diseases in humans. (NIH ODS)
Metformin is one of the most widely studied and prescribed medications for type 2 diabetes globally. Numerous large-scale clinical trials, such as the UK Prospective Diabetes Study (UKPDS), have demonstrated its efficacy in lowering HbA1c levels and reducing the risk of diabetes-related complications and mortality. Its role as a first-line therapy for type 2 diabetes is well-established and supported by major clinical guidelines worldwide. (Cochrane, NIH ODS)
Evidence for its off-label uses:
* **PCOS:** Multiple randomized controlled trials and meta-analyses support the use of Metformin for improving reproductive and metabolic outcomes in women with PCOS, particularly in those with insulin resistance. (Cochrane)
* **Weight Loss:** While not approved as a weight-loss drug, a review of studies has shown that Metformin can lead to modest weight loss over time, especially in overweight or obese individuals with type 2 diabetes or insulin resistance. (Cochrane)
* **Longevity:** Research in this area is primarily preclinical, but human studies, such as the `Targeting Aging with Metformin` (TAME) trial, are underway to investigate its potential to delay age-related diseases. (NIH ODS)
Common side effects of Metformin often involve the gastrointestinal system and include:
* Nausea
* Vomiting
* Diarrhea
* Abdominal pain
* Loss of appetite
These side effects are often transient and can be minimized by starting with a low dose and gradually increasing it, as well as taking the medication with food.
Less common but more serious side effects include:
* **Lactic Acidosis:** This is a rare but potentially fatal complication. Symptoms include unusual muscle pain, difficulty breathing, unusual drowsiness, stomach pain, dizziness, or irregular heartbeat. It is more likely to occur in individuals with kidney problems, liver disease, congestive heart failure, or those consuming excessive alcohol. (FDA label)
* **Vitamin B12 Deficiency:** Long-term use of Metformin can lead to a decrease in vitamin B12 levels, which may cause anemia or nerve problems. Regular monitoring of B12 levels is recommended. (NIH ODS)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
When using Metformin, individuals should be aware of several warnings:
* **Kidney Function:** Metformin is primarily cleared by the kidneys. Impaired kidney function (renal insufficiency) increases the risk of lactic acidosis. Regular monitoring of kidney function is essential before starting and during treatment. The medication may need to be stopped or the dose adjusted if kidney function declines. (FDA label)
* **Liver Disease:** Individuals with severe liver disease should generally avoid Metformin as it can increase the risk of lactic acidosis. (FDA label)
* **Heart Failure:** People with unstable or acute congestive heart failure may be at higher risk for lactic acidosis. (FDA label)
* **Alcohol Consumption:** Excessive alcohol intake significantly increases the risk of lactic acidosis and should be avoided or severely limited while on Metformin. (FDA label)
* **Dehydration:** Conditions leading to dehydration, such as severe vomiting, diarrhea, or fever, can increase the risk of lactic acidosis. It is important to stay well-hydrated. (EMA SmPC)
* **Surgical Procedures/Imaging:** Metformin should typically be temporarily stopped before surgical procedures requiring restricted food or fluid intake, or before imaging procedures involving iodinated contrast agents, and restarted only after kidney function has been assessed as normal. (FDA label)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Metformin is contraindicated in the following situations:
* **Severe Renal Impairment:** Patients with an estimated glomerular filtration rate (eGFR) below a certain threshold (e.g., typically <30 mL/min/1.73m²) due to the increased risk of lactic acidosis. (FDA label)
* **Metabolic Acidosis (including Diabetic Ketoacidosis):** Patients with acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. (FDA label)
* **Hypersensitivity:** Known hypersensitivity to Metformin or any of its components. (EMA SmPC)
* **Acute or Chronic Disease:** Any acute condition with the potential to alter renal function, such as dehydration, severe infection, shock, or acute heart failure.
* **Clinical Conditions:** Clinical conditions that may cause tissue hypoxia (e.g., acute myocardial infarction, septicemia, respiratory failure).
* **Severe Hepatic Insufficiency:** Severe liver impairment may increase the risk of lactic acidosis. (FDA label)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Several substances can interact with Metformin. It's crucial to inform your clinician about all medications, supplements, and herbal products you are taking.
* **Iodinated Contrast Agents:** Used in certain X-ray or CT scans. Metformin should be temporarily discontinued before or at the time of the procedure in patients with impaired renal function, and for 48 hours afterward. (FDA label)
* **Other Medications Affecting Kidney Function:** Drugs that can impair kidney function, such as non-steroidal anti-inflammatory drugs (NSAIDs) or certain diuretics, can increase the risk of lactic acidosis when taken with Metformin. (Mayo Clinic)
* **Alcohol:** Excessive alcohol consumption significantly increases the risk of lactic acidosis. Limit or avoid alcohol entirely while on Metformin. (FDA label)
* **Cationic Drugs:** Medications eliminated by renal tubular secretion (e.g., amiloride, digoxin, morphine, procainamide, quinidine, ranitidine, triamterene, trimethoprim, cimetidine, vancomycin) can potentially compete with Metformin for transport systems, leading to increased Metformin concentrations. (FDA label)
* **Drugs Affecting Glycemic Control:** Some medications can affect blood glucose levels, potentially requiring adjustment of Metformin dosage. Examples include corticosteroids, certain diuretics, thyroid hormones, estrogens, oral contraceptives, phenothiazines, and sympathetic mimetics. Conversely, drugs like NSAIDs, ACE inhibitors, and MAO inhibitors can lower blood glucose. (EMA SmPC)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Metformin is typically taken with meals. Taking it with food helps to reduce common gastrointestinal side effects like nausea, diarrhea, and stomach upset. The specific dosing frequency (e.g., once, twice, or thrice daily) and dosage amount are user-directed and must be set by a licensed clinician based on individual needs, response, and kidney function. Extended-release formulations are often taken once daily with the evening meal. (FDA label, MedlinePlus)
Source for this section: Sources for When should you take Metformin?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Metformin?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Berberine | Caution | Compound pairConfidence: theoretical | Both lower blood sugar, so combining may lower it more than expected.Source pending | Monitor blood sugar and discuss with your provider. |
| Alpha-Lipoic Acid | Note | Compound pairConfidence: theoretical | Alpha-lipoic acid can affect blood sugar, adding to diabetes medication effects.Source pending | Monitor and discuss with your provider. |
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
| Vitamin B12 | Note | Compound pairConfidence: theoretical | Long-term metformin use is associated with reduced B12 absorption and lower serum B12.Source pending | Monitor B12 annually; supplement 500–1000 mcg/day if low. |
| MK-677 | Note | Compound pairConfidence: theoretical | MK-677 can transiently increase fasting glucose; metformin may offset but monitor.Source pending | Monitor fasting glucose and HbA1c when combining. |
Frequently asked questions about Metformin
Metformin is a medication. The references summarized come from NIH and PubMed records, FDA labeling where it exists, and Mayo Clinic patient material.
Metformin is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Metformin, it is typically taken with a meal, it is usually taken with food, and its approximate half-life is 6.2 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.
Metformin carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Metformin is classified as a controlled substance in some jurisdictions, so legal status and prescribing rules apply. Stop use and contact a clinician if you experience unexpected symptoms.
As a medication, Metformin can overlap with other supplements, prescription medicines, hormones and peptides. Because Metformin is usually taken with a meal, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 6.2 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Metformin with no sign-up.
Whether Metformin fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to Metformin. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
With a plasma half-life near 6.2 hours, once-daily dosing is the usual pattern for Metformin. It is typically taken with a meal. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
With a plasma half-life near 6.2 hours, a single missed dose of Metformin usually has a smaller effect on overall exposure than an irregular pattern of missed doses does. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Metformin the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Metformin?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Efficacy and Safety of Metformin for Obesity: A Systematic Review(opens PubMed in a new tab)Pediatrics · 2021 · PMID 33608415 · https://pubmed.ncbi.nlm.nih.gov/33608415/
- 2.Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis(opens PubMed in a new tab)J Clin Endocrinol Metab · 2024 · PMID 37554096 · https://pubmed.ncbi.nlm.nih.gov/37554096/
- 3.Association of metformin use and cancer incidence: a systematic review and meta-analysis(opens PubMed in a new tab)J Natl Cancer Inst · 2024 · PMID 38291943 · https://pubmed.ncbi.nlm.nih.gov/38291943/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 14219(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/14219
Verify at
Publisher search links for Metformin. These are places to check the information — they are not citations, so they are not numbered.
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Metformin?
Plain-text summary, safe to quote verbatim:
Metformin is an oral medication primarily used to manage type 2 diabetes. It belongs to a class of drugs called biguanides. It is typically taken with a meal. The reported plasma half-life is about 6.2 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/metformin
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Metformin — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/metformin
What compounds are similar to Metformin?
Others in the medication category or studied for the same goals.